PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsosteomyelitis
MeSH D010019 - osteomyelitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001850:Infectious bone diseases
$
Success rate
D010019: 
Osteomyelitis
D008417:Mastoiditis
0 Companies
0 Drugs
Success rate
D059270:Petrositis
0 Companies
0 Drugs
Success rate
D059369:Pott puffy tumor
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCiprofloxacin Ciprofloxacin  2004-06-09   
Cloxacillin Cloxacillin  1982-01-01   
Dicloxacillin Dicloxacillin  1982-06-03   
Oxacillin Oxacillin  1982-01-01   
Taro PharmaceuticalCiprofloxacin Ciprofloxacin  2004-10-06   
NATCO PharmaCiprofloxacin Ciprofloxacin  2004-06-09   
GSKOxacillin Bactocill  1982-01-01   
Cloxacillin Cloxapen  1982-01-01   
Dicloxacillin Dycill  1982-01-01   
Nafcillin Nallpen  1982-01-01   
Chartwell PharmaceuticalsDicloxacillin Dicloxacillin  1982-01-01   
Ciprofloxacin Ciprofloxacin  2004-11-04   
SandozNafcillin Nafcillin  1984-08-02   
Oxacillin Oxacillin  1982-01-01   
Ciprofloxacin Ciloxan  1990-12-31   
Hydrocortisone, Ciprofloxacin Cipro  1998-02-10   
Dexamethasone, Ciprofloxacin Ciprodex 2025-06-04 2003-07-18   
WyethDicloxacillin Pathocil  1982-01-01   
Nafcillin Unipen  1986-12-16   
BayerCiprofloxacin Cipro  1987-10-22   
Aurobindo PharmaCiprofloxacin Ciprofloxacin  2007-04-26   
Dicloxacillin Dicloxacillin  2022-09-23   
Barr PharmaceuticalsCiprofloxacin Ciprofloxacin  2004-06-09   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
67%
2/3
Phase 2
67%
6/9
Phase 3
85%
11/13
Approved: 6Overall Success rate: 38%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
GSK
Dr Reddys Laboratories
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use